Low Usefulness of Potassium Monitoring Among Healthy Young Women Taking Spironolactone for Acne
Author(s) -
Molly Plovanich,
Qing Yu Weng,
Arash Mostaghimi
Publication year - 2015
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/jamadermatol.2015.34
Subject(s) - spironolactone , hyperkalemia , medicine , acne , population , aldosterone , mineralocorticoid , dermatology , environmental health
Spironolactone has been shown to be an effective treatment option for hormonally mediated acne but can cause hyperkalemia. The prevalence of hyperkalemia among healthy young women taking spironolactone for acne is unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom